Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Based on results, we create a tailored plan including nutrition guidance, exercise recommendations, and possible medical treatments
Avoid snacks that deliver mostly carbohydrates or fat without meaningful protein
On average, participants experienced a 15% reduction in their body weight over a period of 68 weeks
Retatrutide creates the perfect environment for fat loss through appetite suppression, improved insulin sensitivity, and increased energy expenditure
Zepbound makes sense if you: Want to start treatment now under a licensed prescriber Value a drug with completed Phase 3 data and FDA approval Have insurance coverage or can use the self-pay vial program Prefer a known, regulated safety profile Retatrutide may interest you if you: Are tracking the most aggressive weight-loss results in development Did not reach your goal on tirzepatide and want to know what comes next Are willing to wait for FDA approval rather than buy unregulated material Want to discuss clinical trial enrollment with your doctor For people already on Zepbound who are curious about a future switch, the practical considerations are laid out in switching from tirzepatide to retatrutide
Cutting Calories Too Aggressively on Top of the Compound Retatrutide already creates a significant caloric deficit through appetite suppression
